Equities

Hyphens Pharma International Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Hyphens Pharma International Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SGD)0.34
  • Today's Change-0.005 / -1.45%
  • Shares traded508.00k
  • 1 Year change+19.30%
  • Beta0.0960
Data delayed at least 10 minutes, as of Feb 06 2026 08:02 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Hyphens Pharma International Limited is a Singapore-based specialty pharmaceutical and consumer healthcare company. The Company's principal activities are those of an investment holding company and provision of management services. The Company's segments include Specialty pharma principals, Proprietary brands, and Medical hypermart and digital. The Specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The Proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The Medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position themselves as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.

  • Revenue in SGD (TTM)185.32m
  • Net income in SGD6.46m
  • Incorporated2017
  • Employees474.00
  • Location
    Hyphens Pharma International Ltd16 Tai Seng Street, Level 4 534138SingaporeSGP
  • Phone+65 62965751
  • Fax+65 62931116
  • Websitehttps://www.hyphensgroup.com/
More ▼

Institutional shareholders

1.29%Per cent of shares held by top holders
HolderShares% Held
Amova Asset Management Asia Ltd.as of 30 Jun 20254.00m1.29%
Data from 30 Jan 2026 - 30 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.